2016 Congressional Fly-In

On September 21, PhRMA is bringing more than 60 researchers and scientists from its member companies to meet with members of Congress to discuss how they can help support development of new, innovative medicines for patients in need.

The face-to-face meetings will allow members of Congress the opportunity to directly connect with those researchers and scientists developing innovative new treatments and better understand what drives them.

Researchers will also spotlight the progress made by the biopharmaceutical industry in recent years, including efforts to harness the immune system to fight cancer; the discovery of medicines that can cure more than 90 percent of patients with hepatitis C; and the discovery of more than 500 medicines for the 25 million Americans with rare diseases.